Stephan Kontos

Stephan is the Director of Research at Anokion, driving the technology forward from our research unit at the EPFL. He received his B.Sc. in Chemical Engineering from the University of Texas at Austin and moved to the EPFL for his doctorate in Bioengineering. During his thesis work in Jeff Hubbell’s group, he co-invented and developed the erythrocyte-binding tolerance technology that led to the founding of Anokion. Following completion of his PhD in Bioengineering, Stephan further advanced several design aspects of our core technology as a post-doctoral researcher.

Stephan Kontos is the Chief Scientific Officer at Anokion, based in Switzerland, Europe. With a background in Biotechnology, Stephan Kontos has a rich history of leadership and innovation.Stephan Kontos studied B.Sc. Chemical Engineering at The University of Texas at Austin. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.